TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: number of paroxysms of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of spinal anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Level of antibodies against SARS CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Freedom from device-related or procedure-related major adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of mitral regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: neurological morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glottic visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intubation success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of patients with high fecal blood output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percent Change in Time Averaged Mean Velocity (TAMV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain from venipuncture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient movement during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of mu rhythm BCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Daytime drowsiness
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: CAP-related re-admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Child Perceptions Questionnaire 8-10
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of OTSA101-DTPA-111In
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of OTSA101-DTPA-90Y
Endpoint domain: Adverse events/effects
Primary endpoint: Change in serum oxidative stress marker (malondialdehyde) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Recurrent C. Difficile Infection
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of skin cancer
Endpoint domain: Mortality/survival
Primary endpoint: Women's Health Assessment Questionnaire (WHAQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak Sputum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cesarean section scar evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of malaria infection
Endpoint domain: Adverse events/effects
Primary endpoint: Lower Limb Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lower Limb Spasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Grade III-IV Acute Graft-Versus-Host Disease (GVHD) Free Survival (AGFS)
Endpoint domain: Mortality/survival
Primary endpoint: 3-Month Progression-Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: change in regional brain oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of Extra Vascular Lung Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Drug Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in assessment of depression, anxiety, PTSD
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Reward Deficiency Syndrome Questionnaire (RDSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Table time of Abbreviated PB MRI
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Difference in pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of parent acts imitated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-Reactive Protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate and extent of absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Who Maintained Average Hb Value Within Target Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: increased physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Twitch tracheal pressure during airway occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of Biopsy Proven Acute Rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Sweet taste intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sweet taste liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Intensity of Gastrointestinal Complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Sum Score of Gastrointestinal Complaints
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Patient Satisfaction Referring to Gastrointestinal Complaints
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Duration of Severe Neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of subjects with plasma HIV-1 RNA <50 copies/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interpersonal Needs Questionnaire (INQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: incidence and distribution of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: identification of molecular subtypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Serum Phosphorus Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Recurrence or Death Events
Endpoint domain: Mortality/survival
Primary endpoint: Percent Change in Aging Male Symptoms (AMS) Mean Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Having Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Having Transfusion-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants Achieving PASI 75 Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Body weight measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of recurrent endometrioma formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lens Opacity Classification System III (LOCSIII)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of treatment decisions changed by CTC results
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of treatment decisions for which CTC results add value
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Freedom from serious complications or adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Bristol Stool Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Pregnancy Rate (Expressed as Pearl Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Safety Outcome Measures
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in ESSPRI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Complete Response and Partial Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of orthostatic intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perinatal Death
Endpoint domain: Mortality/survival
Primary endpoint: Acute Survival
Endpoint domain: Mortality/survival
Primary endpoint: Chronic Survival
Endpoint domain: Mortality/survival
Primary endpoint: changes in gait parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of HIV testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of neurological status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post operative pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower grade of mucositis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of exenatide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacodynamics of exenatide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving Minimal Disease Activity (MDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Clinician Administered PTSD Scale (CAPS)-5 Severity Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Number of Drinks Per Drinking Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD Checklist-5
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gait velocity during self-selected overground walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak dorsiflexion angle during swing phase of gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ankle dorsiflexion-plantarflexion range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Neutrophils recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelets recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Volume correction with Art Filler Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume correction with Art Filler Lips
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of self-assessment of medical abortion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant nutritional status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional Communication Classification System (FCCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication Function Classification System (CFCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual Ability Classification System (MACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline gait speed at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline balance at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline frailty index at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beat to beat variation of the electrical activation vector of the atrium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Wheal size area (mm2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction / improvement of signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients developing hepatic encephalopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of the Ad4-H5-Vtn recombinant vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Need for mechanical ventilation following the initiation of NCPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proresolution Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of Proresolving Mediators at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of Proinflammatory Mediators at 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Correct Answers in Biber Cognitive Estimation Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average response latency in Stroop Effect test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average Score in Digit Span test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average Score in Backwards Digit Span test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average percentage of correct answers in Stroop Effect test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Necrotising enterocolitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Effect on T regulatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline to Week 12 in the Non-Motor Symptom Scale (NMSS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Antidepressive efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Observed Health Care Personnel Time for Anemia Management
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of Patients Who Did Not Require Rescue Antihypertensive Medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinical in-hospital complications
Endpoint domain: Adverse events/effects
Primary endpoint: cancer-specific anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: quality of life concerns
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of amino acid absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of amino acid absorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax for Saxagliptin and Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(0-T) for Saxagliptin and Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC(INF) for Saxagliptin and Metformin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Days alive without intensive care or high dependency unit treatment
Endpoint domain: Mortality/survival
Primary endpoint: Annualized Rate of Serious Bacterial Infection (Intention-to-Treat Population)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Annualized Rate of Serious Bacterial Infection (Per-Protocol Efficacy Population)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Subjects With Anti-PRP Antibody Concentrations ≥ 0.15 µg/mL and ≥ 1.0 µg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lung aeration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Seroprotected Subjects for Anti-polyribosylribitol Phosphate (Anti-PRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Seropositive Subjects Against Neisseria Meningitidis Using Baby Rabbit Complement (rSBA-MenC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number and the type of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of headache frequency and intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Average Pain Over the Last 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brief Edinburg Depression Scale (BEDS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of Coxiella burnetii infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percent of Patients Reaching Target HR<100bpm Within 30 Minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Muscle Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-Bearing Line at Final Correction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Standard Drinks Per Week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death or bronchopulmonary dysplasia at 28 days
Endpoint domain: Mortality/survival
Primary endpoint: Progressive Survival (PFS) at Six Months
Endpoint domain: Mortality/survival
Primary endpoint: Progressive Survival (PFS) at Three Months
Endpoint domain: Mortality/survival
Primary endpoint: Percent Reduction From Baseline in Urinary Albumin to Creatinine Ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Herpes labialis relapses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: New MRSA or skin infection
Endpoint domain: Adverse events/effects
Primary endpoint: Functional brain changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in modified questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of temperature measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rate I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rate II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer (GMT) I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric mean titer (GMT) II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Contact Lens Corrected Distance Visual Acuity (CLCDVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the growth intensity of the nasal Staphylococcus aureus colony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: NT-pro-BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Daily physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Related-complications
Endpoint domain: Adverse events/effects
Primary endpoint: 60 day survival
Endpoint domain: Mortality/survival
Primary endpoint: Relative number of prescriptions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Relative treatment compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Self-reported family communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Progression Free Survival (PFS) at 9 Month
Endpoint domain: Mortality/survival
Primary endpoint: Nerve growth factor quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rate of fogging or smearing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of extraction for cleaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time consumption for lens cleaning
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants With Vaginal Mesh or Suture Exposure
Endpoint domain: Adverse events/effects
Primary endpoint: lowest pulse oxymetry (SpO2) during intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pulse oxymetry during intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulse oxymetry after preoxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulse oxymetry after intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in HbA1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean Systolic and Diastolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Heart Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerated dose (MTD) of EPO906
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMCL and IHCL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes